Anissa Zarour

Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database

Léa Hoisnard, Bénédicte Lebrun‐Vignes, Sébastien Maury et al. · Scientific Reports · 2022 · 171 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Long‐term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP‐ritux

Samuel Deshayes, Mehdi Khellaf, Anissa Zarour et al. · American Journal of Hematology · 2019 · 86 citations · Full text

Medicine, Hematology, Immunology +12

Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study

S. Guillet, Valentine Loustau, Emmanuelle Boutin et al. · Blood · 2022 · 47 citations · Full text

Medicine, Hematology, Obstetrics +15

Belatacept in renal transplant recipient with mild immunologic risk factor: A pilot prospective study (BELACOR)

Claire Leibler, Marie Matignon, Anissa Moktefi et al. · American Journal of Transplantation · 2018 · 43 citations · Full text

Life Sciences, Immunology, Nephrology +17

Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study

S. Guillet, Étienne Crickx, Imane Azzaoui et al. · Blood · 2023 · 28 citations

Medicine, Hematology, Pharmacotherapy +8